Imagion Biosystems Ltd
(ASX:IBX)

Latest Article

One ASX Med-Tech is Set to Transform The $100+Billion Cancer Diagnostic Market

One ASX Med-Tech is Set to Transform The $100+Billion Cancer Diagnostic Market

MagSense is a unique, non-invasive, patent protected technology that fits into myriad addressable cancer diagnostic markets collectively worth $166 billion dollars and growing at 7% annually.

Thanks for subscribing!

X